Login / Signup

Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3.

Ishmael A JaiyesimiNatasha B LeighlNofisat IsmailaKrishna C AlluriNarjust FlorezShirish M GadgeelGregory A MastersErin L SchenkBryan J SchneiderLecia V SequistNavneet SinghLyudmila BazhenovaElizabeth BlanchardJanet Freeman-DailyNaoki FuruyaBalazs HalmosIbrahim Hanna AzarSara KuruvillaMichael MullaneJarushka NaidooJoshua E ReussDavid R SpigelDwight H OwenJyoti D Patel
Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Evidence-based recommendations were updated to address first, second, and subsequent treatment options for patients without driver alterations.Additional information is available at www.asco.org/living-guidelines.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • clinical practice
  • prognostic factors
  • patient reported outcomes